TRENDS OF CANCER OBSERVED IN A PREMIER INSTITUTE IN MUMBAI, INDIA DURING LAST THREE DECADES Dr. Ganesh B. Prof. & Head, Department of Medical Records,

Slides:



Advertisements
Similar presentations
National Institute of Oncology Rabat-Morocco. National Institute of Oncology I.N.O. Rabat, Morocco : New Cases.
Advertisements

Implementation of the Navigator Role in Community – Based Oncology Program Our Journey Joan M. Daugherty, RN, MS Executive Director, Richard A. Henson.
Palestinian National Authority Ministry of Health Cancer Registry Center 2006 Dr.Bayan El Sakka General Directors of Cancer Registry.
LEUKEMIA & LYMPHOMA SOCIETY TEAM IN TRAINING. THE LEUKEMIA & LYMPHOMA SOCIETY WORLDS LARGEST VOLUNTARY HEALTH ORGANIZATION DEDICATED TO FUNDING BLOOD.
Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
CANCER MAGNITUDE OF PROBLEM
NATIONAL POPULATION BASED- CANCER REGISTRY- Dr. G.Z. Mutuma Principal Research Officer, Head, Non-Communicable Diseases Research Programme, Kenya Medical.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Overview of All SEER-Medicare Publications Through 2012 Mark D. Danese, MHS, PhD July 24, 2012.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
Case for Support. Blood Cancers More than 1 million North Americans are fighting blood cancers, the third leading cause of cancer deaths. Early detection.
A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.
Cancer Among Native Americans in Arizona and New Mexico Data Provided by Arizona Cancer Registry at the Arizona Department of Health Services and the New.
Nico van Zandwijk Head of the Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands Former secretary and chairman of.
Electronic Cancer Referral Dr Regina Codd GP Community Oncology Team NCCP.
Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.
START PROGRAM: STATE-OF-THE-ART ONCOLOGY IN EUROPE RARECARENet kick-off Luxembourg – July 13, 2012 Chairperson: Dr. Lisa Licitra.
HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Cancer.
Role of the Surgeon in Cancer Management A. Responsible for the initial diagnosis and management of solid tumors. B. Responsible for the Definitive Surgical.
Associated Web sites CustomizableMaps The Atlas On-Line.
EEOICPA Compensation Results (through March 2004) Russ Henshaw, MS Epidemiologist NIOSH/Office of Compensation Analysis & Support Cincinnati, OH.
Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.
Dr Heather O Dickinson Department of Child Health University of Newcastle
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
COUNTRY REPORT: PHILIPPINES Dr. Miriam Joy C. Calaguas.
Improvement in Quality of Radiotherapy for Frequent Cancers Chinese Academy of Medical Sciences Cancer Hospital Manni Huang.
Department of Preventive Medicine Faculty of Public Health University of Debrecen General Practitioners’ Morbidity Sentinel Stations Program (GPMSSP) to.
Enhancing Incidence Data with Passive End-Results Jill MacKinnon, Sarah Manson, and Mayra Alvarez Florida Cancer Data System.
RT-PCR: RBP-MS, T52 T53 (427 bp), Reamplifikation _Reampli_Gewebe_1_B1_T52T53_calb Bedingungen: 2% TBE 90V 1h 45min 9 µ Reampli-Probe 2 µl LB M 1.
Yueh-Han Hsu 1,2, MD, MPH, PhD; Wen-Chen Tsai 2, DrPH; Wei Chen 1, MD 1 Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi City, Taiwan 2.
Malawi National Cancer Registry update SJD Chasimpha Malawi Cancer Symposium Lilongwe August, 2016.
What is cancer?. Cancer Development of abnormal cells Divide uncontrollably Can infiltrate and destroy normal body tissue.
Qualified Patient Criteria Combinations (Female and Male) Personal History of (any one of the below): Breast or Ovarian cancer (any age) Prostate or Pancreatic.
COLORECTAL CANCER: Global Trends & Implications for Uganda
Omega Best Cancer Hospital - India
2 Incidence SABER This module presents statistics from Chapter 2: Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
Survival in most affluent
Incidence and Treatment Patterns in Hospitalizations for Malignant Spinal Cord Compression in the United States, 1998–2006  Kimberley S. Mak, B.A., Leslie.
Innovations in Public Health Care System in Odisha
3 Mortality ANIQ This module presents statistics from Chapter 3: Mortality Ontario Cancer Statistics 2016 Chapter 3: Mortality.
Cancer Waiting Times, UK countries   England Wales Scotland
Clinicopathological features and outcome of Head & Neck Cancer in Pakistan 1A Jamshed, 1R Hussain, 2S Jamshed, 1A A Syed, 1A Loya, 1M A Shah, 1U Majeed.
Cancer in Ontario 1 An Overview
Developing a Comprehensive Site Selection Process for a Cancer Network in a Resource-Limited Settings in Sub-Saharan Africa Meg Wirth AMC Operations &
Head of Policy and Public Affairs
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
CANCER Carbon Co. Luzerne Schuylkill Pennsylvania TABLE 1. Distribution of Cancers by Type for Tamaqua Study Counties and Pennsylvania Based on
NCD Control Programmes
Non-Communicable Diseases Lesson 7
Cancer Epidemiology Kara P. Wiseman, MPH, Phd
Bronx Community Health Dashboard: Other Cancers Last Updated: 01/09/2018 See last slide for more information about this project.
Supplementary Figures
Volume 384, Issue 9945, Pages (August 2014)
5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Estimated current cancer incidence
Estimated current cancer mortality
The 20 Most Common Cancers in 2012
The Development of an E-Cancer Registry
Fetal Pig Dissection with comparison to the human models
Clinical and Epidemiological Profile of children receiving
Demographic and Epidemiological Transition and Cancer in India
Siwei Zhang Rongshou Zheng
Andrea Sipin-Baliwas Los Angeles Cancer Surveillance Program
Recent Incidences and Trends of the Top Cancers in Northeast Tennessee Appalachian Region Adekunle Oke1, Sylvester Orimaye2, Ndukwe Kalu1, Dr. Faustine.
Trends of mortality rates in the USA between 1930 and 2000 in males according to cancer site. –––––: stomach; ·······: prostate; –– –– ––: colon and rectum;
Presentation transcript:

TRENDS OF CANCER OBSERVED IN A PREMIER INSTITUTE IN MUMBAI, INDIA DURING LAST THREE DECADES Dr. Ganesh B. Prof. & Head, Department of Medical Records, Biostatistics & Epidemiology, Tata Memorial Hospital, Mumbai, INDIA

About Tata Memorial Hospital … Tata Memorial Centre is amongst the oldest and largest cancer centres in the world, with over 75 years of exceptional patient care, high-quality training and innovative cancer research. Over the years, it has grown in size and stature, maintaining its pre-eminent position at the forefront of national and global cancer control efforts. Compassionate patient care remains the major focus of Tata Memorial Centre, with eleven Disease Management Groups (or multidisciplinary teams) breaking departmental silos and providing optimal care for every patient. This emphasis on team approach leverages the extensive experience and expertise of various specialists, thereby providing patients with evidence-based, yet individualized care, tailored not just to the cancer but also the patient’s unique physical, emotional and psychosocial needs. Researchers at the Tata Memorial Centre are world leaders in basic, translational, epidemiologic and clinical cancer research. Research at TMC includes studies to understand cancer biology, large community based screening trials for common cancers and cohort studies, neoadjuvant and adjuvant treatment, perioperative interventions, surgical trials, repurposing drugs and qualitative research to understand the patient journey. Our research focuses on impacting survival and quality of life i.e., living longer, or living better –endpoints that really matter to patients. Training and education form a major focus area for TMC, which remains the most sought after institution for oncology training nationally. Combining a world-class academic faculty and being amongst the highest volume cancer centres in the world, we take special pride that our alumni now provide specialist oncology care and hold leadership positions in several cancer centres in the country and internationally.

Tata Memorial Hospital Based Cancer Registry 1941 Hospital-Based Cancer Registry (HBCR) is functional since inception of the hospital 1941-1985 Several clinical and survival studies were published utilizing the HBCR data. Due to non-existence of computers, all statistical analysis was done manually using 80-coulmn punch cards, Sorting machines and Calculators 1963 Mumbai Cancer Registry was established in the premises of Tata Memorial Hospital (TMH) under Indian Cancer Society. All technical and administrative assistance was provided by TMH. 1982 Technical Wing of the National Cancer Registry Programme (NCRP), Indian Council of Medical Research (ICMR) was established in TMH premises 1985 Cancer Registry software was developed and Online data entry initiated. HBCR of TMH joined the network of National Cancer Registry Programme (NCRP) of Indian Council of Medical Research (ICMR). Annual submission of data to NCRP was initiated from the year 1987. The first Report of the TMH HBCR-NCRP network effort of 1984 registered cases seen in TMH was published in the year 1987.

Trend of All Cancers- 1985-2014 Source: HBCR, Tata Memorial Hospital , Mumbai

Trend of Cancer by Residence Source: HBCR, Tata Memorial Hospital , Mumbai

Head & Neck Cancers - Male Site % Change Hypopharynx 6.9 ­ Larynx 3.4 Oral Cavity 9.3  Oropharynx 8.7 Source: HBCR, Tata Memorial Hospital , Mumbai

Head & Neck Cancers - Male Site % Change Nasopharynx 0.4 ­ Para Nasal Sinus 0.6 Salivary Gland (Major) 0.1 ¯ Source: HBCR, Tata Memorial Hospital , Mumbai

Head & Neck Cancers - Female Site % Change Hypopharynx 1.7 ¯ Nasopharynx 0.0   Oral Cavity 0.4  Oropharynx 1.0 Source: HBCR, Tata Memorial Hospital , Mumbai

Head & Neck Cancers - Female Site % Change Larynx 0.2  Para Nasal Sinus 0.7 Salivary Gland (Major) 0.1 Source: HBCR, Tata Memorial Hospital , Mumbai

Gastrointestinal Cancers - Male Site % Change Colon 1.0  Gall Bladder 2.8 Oesophagus 4.8 ­ Pancreas 1.2 Source: HBCR, Tata Memorial Hospital , Mumbai

Gastrointestinal Cancers - Male Site % Change Anal Canal 0.1  Liver 1.6 Rectum 1.0 Small Intestine 0.2 Stomach 1.2 Source: HBCR, Tata Memorial Hospital , Mumbai

Gastrointestinal Cancers - Female Site % Change Colon 1.0 ­ Gall Bladder 5.5 Liver 0.6 Oesophagus 2.5  Source: HBCR, Tata Memorial Hospital , Mumbai

Gastrointestinal Cancers - Female Site % Change Anal Canal 0.1 ­ Pancreas 1.0 Rectum 0.7 Stomach 0.6 Source: HBCR, Tata Memorial Hospital , Mumbai

Genito-Urinary Cancers - Male Site % Change Kidney 1.0 ­ Urinary Bladder 1.1 Prostate 1.9 Testis 0.5  Penis 0.1 Source: HBCR, Tata Memorial Hospital , Mumbai

Genito-Urinary Cancers - Female Site % Change Kidney 0.3 ­ Urinary Bladder 0.1 Cervix 21.5  Ovary 2.4 Corpus Uteri 1.1 Source: HBCR, Tata Memorial Hospital , Mumbai

Hematolymphoid Malignancies- Male Site % Change Leukemia 0.9 ­ Multiple Myeloma 0.6 Non-Hodgkins Lymphoma 0.8 Hodgkins Disease ¯ Source: HBCR, Tata Memorial Hospital , Mumbai

Hematolymphoid Malignancies- Female Site % Change Leukemia 1.2 ­ Multiple Myeloma 0.2 Non-Hodgkins Lymphoma Hodgkins Disease 0.3  Source: HBCR, Tata Memorial Hospital , Mumbai

Trends in Common Cancers Site % Change Head & Neck 7.0 ¯ Breast 5.8 ­ Cervix 21.5 Years Source: HBCR, Tata Memorial Hospital , Mumbai

Comparison with other HBCRs – 1984-1993 Source: NCDIR, India

Comparison with other HBCRs – 1999-2003 Source: NCDIR, India

Clinical Extent of Disease – Head & Neck Cancers Source: HBCR, Tata Memorial Hospital , Mumbai

Trends in Treatment Modalities – Head & Neck Cancers 1985 1994 1999 1989 2004 2009 2014

Clinical Extent of Disease – Breast Cancer Source: HBCR, Tata Memorial Hospital , Mumbai

Trends in Treatment Modality – Breast Cancer 1985 1994 1999 1989 2004 2009 2014 Source: HBCR, Tata Memorial Hospital , Mumbai

Clinical Extent of Disease at time of presentation at TMH – Cervix Cancer Source: HBCR, Tata Memorial Hospital , Mumbai

Trends in Treatment Modality – Cervix Cancer 1985 1994 1999 1989 2004 2009 2014 Source: HBCR, Tata Memorial Hospital , Mumbai

Downstaging of Cervical Cancer over the years Source: HBCR, Tata Memorial Hospital , Mumbai

Bone Marrow Transplants at TMH Years Source: HBCR, Tata Memorial Hospital , Mumbai

Thank you